Consumo de bebidas alcohólicas y energizantes y su perfil lipídico en jóvenes adultos
Palabras clave:
bebidas alcohólicas, bebidas energizantes, perfil lipídico, colesterol, triglicéridosResumen
DOI: https://doi.org/10.46296/gt.v9i18edespsep.0455
Resumen
El presente estudio analizó el consumo de bebidas alcohólicas y energizantes y su relación con el perfil lipídico en jóvenes adultos de 18 a 35 años. Esta investigación utilizó un enfoque cuantitativo, con un diseño no experimental, descriptivo y transversal. La muestra estuvo conformada por 30 participantes de ambos sexos a quienes se les aplicó un cuestionario para identificar los patrones de consumo de bebidas alcohólicas y energizantes, así como la disposición de los mismos para poder evaluar ciertos analitos relacionados con el perfil lipídico. Para lograr cumplir el objetivo de analizar los patrones de consumo de estas bebidas y su importancia como posibles factores asociados al riesgo cardiovascular en jóvenes adultos. Los resultados obtenidos indicaron que el 73,3% de los participantes consumía bebidas alcohólicas, mientras que el 63,3% reportó consumir bebidas energizantes. Asimismo, se evidenció una frecuencia considerable de consumo de ambas bebidas dentro de la población de estudio; estos hallazgos permiten identificar prácticas de consumo que podrían constituir factores de interés para la vigilancia de alteraciones metabólicas y cardiovasculares durante la adultez. La información bibliográfica señala que el consumo de alcohol puede relacionarse con modificaciones en las concentraciones de lipoproteínas, mientras que las bebidas energizantes han sido asociadas con diversos trastornos metabólicos y cardiovasculares.
Palabras claves: bebidas alcohólicas, bebidas energizantes, perfil lipídico, colesterol, triglicéridos.
Abstract
The present study analyzed the consumption of alcoholic and energy drinks and their relationship with the lipid profile in young adults aged 18 to 35 years. This research used a quantitative approach with a non-experimental, descriptive, and cross-sectional design. The sample consisted of 30 participants of both sexes, who were administered a questionnaire to identify patterns of alcoholic and energy drink consumption, as well as their willingness to undergo the evaluation of certain analytes related to the lipid profile. The study aimed to analyze the consumption patterns of these beverages and their importance as potential factors associated with cardiovascular risk in young adults. The results showed that 73.3% of the participants consumed alcoholic beverages, while 63.3% reported consuming energy drinks. Likewise, a considerable frequency of consumption of both types of beverages was observed among the study population. These findings allow for the identification of consumption practices that could constitute factors of interest for monitoring metabolic and cardiovascular alterations during adulthood. The available literature indicates that alcohol consumption may be associated with changes in lipoprotein concentrations, while energy drinks have been linked to various metabolic and cardiovascular disorders.
Keywords: alcoholic beverages, energy drinks, lipid profile, cholesterol, triglycerides.
Información del manuscrito:
Fecha de recepción: 23 de junio de 2026.
Fecha de aceptación: 15 de agosto de 2026.
Fecha de publicación: 23 de septiembre de 2026.
Descargas
Citas
Ajibo, C., Van Griethuysen, A., Visram, S., & Lake, A. A. (2024a). Consumption of energy drinks by children and young people: a systematic review examining evidence of physical effects and consumer attitudes. Public Health, 227, 274–281. https://doi.org/10.1016/j.puhe.2023.08.024
Ajibo, C., Van Griethuysen, A., Visram, S., & Lake, A. A. (2024b). Consumption of energy drinks by children and young people: a systematic review examining evidence of physical effects and consumer attitudes. Public Health, 227, 274–281. https://doi.org/10.1016/j.puhe.2023.08.024
Borén, J., & Taskinen, M. R. (2022). Metabolism of Triglyceride-Rich Lipoproteins. Handbook of Experimental Pharmacology, 270, 133–156. https://doi.org/10.1007/164_2021_520
Castillo-García, A., Valenzuela, P. L., Saco-Ledo, G., Carrera-Bastos, P., Ruilope, L. M., Santos-Lozano, A., & Lucia, A. (2024). Lifestyle and cardiovascular risk in working young adults: insights from a nationwide Spanish cohort. Revista Española de Cardiología (English Edition), 77(10), 821–831. https://doi.org/10.1016/j.rec.2024.02.006
Dalal, J. J., & Khan, T. (2024). Managing dyslipidaemia in young adults. Indian Heart Journal, 76(Suppl 1), S101–S103. https://doi.org/10.1016/j.ihj.2023.11.265
De Giorgi, A., Valeriani, F., Gallè, F., Ubaldi, F., Bargellini, A., Napoli, C., Liguori, G., Romano Spica, V., Vitali, M., & Protano, C. (2022). Alcohol Mixed with Energy Drinks (AmED) Use among University Students: A Systematic Review and Meta-Analysis. Nutrients, 14(23), 4985. https://doi.org/10.3390/NU14234985/S1
Faulkner, R., & Jo, Y. (2022). Synthesis, function, and regulation of sterol and nonsterol isoprenoids. Frontiers in Molecular Biosciences, 9. https://doi.org/10.3389/FMOLB.2022.1006822
Haslam, D. E., Chasman, D. I., Peloso, G. M., Herman, M. A., Dupuis, J., Lichtenstein, A. H., Smith, C. E., Ridker, P. M., Jacques, P. F., Mora, S., & McKeown, N. M. (2022). Sugar-Sweetened Beverage Consumption and Plasma Lipoprotein Cholesterol, Apolipoprotein, and Lipoprotein Particle Size Concentrations in US Adults. The Journal of Nutrition, 152(11), 2534. https://doi.org/10.1093/JN/NXAC166
Hwang, C. L., Piano, M. R., & Phillips, S. A. (2021). The effects of alcohol consumption on flow-mediated dilation in humans: A systematic review. Physiological Reports, 9(10). https://doi.org/10.14814/PHY2.14872
Keirns, B. H., Sciarrillo, C. M., Koemel, N. A., & Emerson, S. R. (2021). Fasting, non-fasting and postprandial triglycerides for screening cardiometabolic risk. Journal of Nutritional Science, 10, e75. https://doi.org/10.1017/JNS.2021.73
Khatiwada, A., Christensen, S. H., Rawal, A., Dragsted, L. O., Berg-Beckhoff, G., & Wilkens, T. L. (2025). Effect of moderate alcohol intake on blood apolipoproteins concentrations: A meta-analysis of human intervention studies. Nutrition, Metabolism and Cardiovascular Diseases, 35(7). https://doi.org/10.1016/j.numecd.2025.103854
Khouja, C., Kneale, D., Brunton, G., Raine, G., Stansfield, C., Sowden, A., Sutcliffe, K., & Thomas, J. (2022). Consumption and effects of caffeinated energy drinks in young people: an overview of systematic reviews and secondary analysis of UK data to inform policy. BMJ Open, 12(2), e047746. https://doi.org/10.1136/BMJOPEN-2020-047746
Kilcoyne, J., & Assaassa, A. (2023). Alcohol and Cardiac Arrythmias: A Review of the Current Data. Reviews in Cardiovascular Medicine, 24(4). https://doi.org/10.31083/J.RCM2404105
Medrano-Sanchez, E. J., Gutierrez-Berrocal, C. A., Gonzales-Aguilar, L. C., Huaman, M. A., Monteza, K. C., & Ayllon, M. L. (2026). Energy Drinks and Cardiovascular Health: A Critical Review of Recent Evidence. Beverages, 12(1), 4. https://doi.org/10.3390/BEVERAGES12010004/S1
Nikniaz, L., Abbasalizad-Farhangi, M., Vajdi, M., & Nikniaz, Z. (2021). The association between Sugars Sweetened Beverages (SSBs) and lipid profile among children and youth: A systematic review and dose-response meta-analysis of cross-sectional studies. Pediatric Obesity, 16(7). https://doi.org/10.1111/IJPO.12782
Organizacion Mundial de la Salud. (2024, June 25). Alcohol. https://www.who.int/es/news-room/fact-sheets/detail/alcohol
Park, S., & Park, B. (2026). Changes in alcohol consumption and their association with lipid profiles among Korean adults aged 40-69 years: the Korea Genome and Epidemiology Study. Nutrition, Metabolism and Cardiovascular Diseases, 36(7). https://doi.org/10.1016/j.numecd.2026.104643
Ray, K. K., Ference, B. A., Séverin, T., Blom, D., Nicholls, S. J., Shiba, M. H., Almahmeed, W., Alonso, R., Daccord, M., Ezhov, M., Olmo, R. F., Jankowski, P., Lanas, F., Mehta, R., Puri, R., Wong, N. D., Wood, D., Zhao, D., Gidding, S. S., … Santos, R. D. (2022). World Heart Federation Cholesterol Roadmap 2022. Global Heart, 17(1), 75. https://doi.org/10.5334/GH.1154
Reyes-Soffer, G., Ginsberg, H. N., Berglund, L., Duell, P. B., Heffron, S. P., Kamstrup, P. R., Lloyd-Jones, D. M., Marcovina, S. M., Yeang, C., & Koschinsky, M. L. (2022). Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association. Arteriosclerosis, Thrombosis, and Vascular Biology, 42(1), E48–E60. https://doi.org/10.1161/ATV.0000000000000147
Salinas, M., Torreblanca, R., Sanchez, E., Blasco, Á., Flores, E., & López-Garrigós, M. (2024). Managing laboratory test ordering: a challenge in the new laboratory medicine model. Advances in Laboratory Medicine, 5(3), 236. https://doi.org/10.1515/ALMED-2024-0085
Stone, N. J., Smith, S. C., Orringer, C. E., Rigotti, N. A., Navar, A. M., Khan, S. S., Jones, D. W., Goldberg, R., Mora, S., Blaha, M., Pencina, M. J., & Grundy, S. M. (2022). Managing Atherosclerotic Cardiovascular Risk in Young Adults: JACC State-of-the-Art Review. Journal of the American College of Cardiology, 79(8), 819–836. https://doi.org/10.1016/j.jacc.2021.12.016
Tamaki, Y., Yaku, H., Morimoto, T., Inuzuka, Y., Ozasa, N., Yamamoto, E., Yoshikawa, Y., Miyake, M., Kondo, H., Tamura, T., Kitai, T., Iguchi, M., Nagao, K., Nishikawa, R., Kawase, Y., Morinaga, T., Kawato, M., Toyofuku, M., Sato, Y., … Kimura, T. (2021). Lower In‐Hospital Mortality With Beta‐Blocker Use at Admission in Patients With Acute Decompensated Heart Failure. Journal of the American Heart Association, 10(13). https://doi.org/10.1161/JAHA.120.020012
Wilkens, T. L., Tranæs, K., Eriksen, J. N., & Dragsted, L. O. (2022). Moderate alcohol consumption and lipoprotein subfractions: a systematic review of intervention and observational studies. Nutrition Reviews, 80(5), 1311–1339. https://doi.org/10.1093/NUTRIT/NUAB102
Wilson, P. W. F., Jacobson, T. A., Martin, S. S., Jackson, E. J., Le, N. A., Davidson, M. H., Vesper, H. W., Frikke-Schmidt, R., Ballantyne, C. M., & Remaley, A. T. (2021). Lipid measurements in the management of cardiovascular diseases: Practical recommendations a scientific statement from the national lipid association writing group. Journal of Clinical Lipidology, 15(5), 629–648. https://doi.org/10.1016/j.jacl.2021.09.046
Zanotti, I., Potì, F., & Cuchel, M. (2022). HDL and reverse cholesterol transport in humans and animals: Lessons from pre-clinical models and clinical studies. Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, 1867(1). https://doi.org/10.1016/j.bbalip.2021.159065
Publicado
Cómo citar
Número
Sección
Derechos de autor 2026 Revista Científica Arbitrada en Investigaciones de la Salud GESTAR. ISSN: 2737-6273.
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
